Group Work in Graduate Social Work Education: Where Are We Now?

This paper presents the preliminary results of a national survey assessing the extent of group work offerings within masters level social work programs in the United States. The study replicates and expands upon a 1994 investigation by Birnbaum and Auerbach. Findings are compared with the earlier study to identify changes and trends in group work education

Domestic Violence or Elder Abuse? Why It Matters for Older Women

Law enforcement and legal services are 2 systems that respond to reports of abuse against women through programs such as adult protective services (APS) and domestic violence (DV). APS and DV systems operate independently and define the cause of the abuse differently. The designation of a woman as having suffered domestic violence or having been abused often depends on which system she enters. This designation can lead to different options for women to obtain services. Aging may further complicate access and usability of these systems to respond to the needs of abused elderly. Using vignettes, this article explores the definitions of abuse and highlights specific concerns of aging that impact usefulness of services

Services to abused and neglected children: Results of a national survey of nonresidential agencies and programs.

Services to abused and neglected children: Results of a national survey of nonresidential agencies and programs

How COVID-19 and Racial Justice Protests Influenced Social Workers’ Perceptions of Policy and Political Participation

Drawing on political opportunity theory, this study examined how the political context created by the COVID-19 pandemic and Black Lives Matter protests influenced social workers’ perceptions about social welfare policy and political participation in the summer of 2020. Authors conducted a thematic analysis of the open-ended survey responses of 120 social work practitioners. Regarding perceptions of policy, respondents reported that they experienced new awareness about the breadth and depth of structural racism in the United States; that they held pessimistic views of the government’s ability to mitigate harm associated with the pandemic or racial injustice; and that structural change, including the expansion of the social safety net, was needed. Regarding participation, respondents described how they used new forms of political engagement in part because of social distancing, but even more so because they were motivated by highly visible acts of racial injustice. At the same time, they experienced barriers to participation including a fear that they were not adequately prepared and asked for additional support from social work professional organizations. Respondents believed that more education is needed about racial justice and political action. These findings have important implications for social work education and practice, especially work to promote social justice

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Background This study was undertaken to determine whether use of the direct renin inhibitor aliskiren would reduce cardiovascular and renal events in patients with type 2 dia- betes and chronic kidney disease, cardiovascular disease, or both. Methods In a double-blind fashion, we randomly assigned 8561 patients to aliskiren (300 mg daily) or placebo as an adjunct to an angiotensin-converting\u2013enzyme inhibitor or an angiotensin-receptor blocker. The primary end point was a composite of the time to cardiovascular death or a first occurrence of cardiac arrest with resuscitation; nonfatal myocardial infarction; nonfatal stroke; unplanned hospitalization for heart failure; end-stage renal disease, death attributable to kidney failure, or the need for renal-replacement therapy with no dialysis or transplantation available or initiated; or doubling of the baseline serum creatinine level. Results The trial was stopped prematurely after the second interim efficacy analysis. After a median follow-up of 32.9 months, the primary end point had occurred in 783 patients (18.3%) assigned to aliskiren as compared with 732 (17.1%) assigned to placebo (hazard ratio, 1.08; 95% confidence interval [CI], 0.98 to 1.20; P=0.12). Effects on secondary renal end points were similar. Systolic and diastolic blood pres- sures were lower with aliskiren (between-group differences, 1.3 and 0.6 mm Hg, respectively) and the mean reduction in the urinary albumin-to-creatinine ratio was greater (between-group difference, 14 percentage points; 95% CI, 11 to 17). The proportion of patients with hyperkalemia (serum potassium level, 656 mmol per liter) was significantly higher in the aliskiren group than in the placebo group (11.2% vs. 7.2%), as was the proportion with reported hypotension (12.1% vs. 8.3%) (P<0.001 for both comparisons). Conclusions The addition of aliskiren to standard therapy with renin\u2013angiotensin system block- ade in patients with type 2 diabetes who are at high risk for cardiovascular and renal events is not supported by these data and may even be harmful